DelMar Pharmaceuticals, Inc. Gains 41.5%

Tue 21 Jul 20 at 05:33 PM
DelMar Pharmaceuticals, Inc. Gains 41.5%

DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ) rocketted at $1.4, representing a gain of 41.5%. On Mon 20 Jul 20, DMPI:NASDAQ hit a New 2-Week High of $0.99. The stock appeared on our News Catalysts scanner on Fri 17 Jul 20 at 08:23 AM in the 'ACQUISITION' category. From Mon 06 Jul 20, the stock recorded 70.00% Up Days and 63.64% Green Days

The stock spiked on Wed 10 Jun 20 at $1.53 with a volume of 5M+.

About DelMar Pharmaceuticals, Inc. (DMPI:NASDAQ)

DelMar Pharmaceuticals Inc is a clinical stage drug development company. It is engaged in research and development of cancer indications.

Share